Non-Inferiority of Sutureless Aortic Valve Replacement in the TAVR Era: David versus Goliath.
Alina ZubarevichMarcin SzczechowiczLukman AmanovArian Arjomandi RadAnja OsswaldSaeed TorabiArjang RuhparwarAlexander WeymannPublished in: Life (Basel, Switzerland) (2022)
Sutureless aortic valve replacement constitutes a feasible treatment alternative for patients with aortic valve disease who are ineligible for transfemoral access route and/or require concomitant coronary revascularization. With its excellent hemodynamic performance, similar survival compared to TA-TAVR, and high cost-efficiency without compromising the postoperative outcomes and in-hospital length of stay SU-AVR might be considered for patients in the "grey-area" between TAVR and SAVR.
Keyphrases
- aortic valve replacement
- aortic valve
- aortic stenosis
- ejection fraction
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- end stage renal disease
- coronary artery disease
- left ventricular
- newly diagnosed
- healthcare
- peritoneal dialysis
- patients undergoing
- emergency department
- type diabetes
- percutaneous coronary intervention
- prognostic factors
- adipose tissue
- combination therapy
- coronary artery bypass grafting
- heart failure
- free survival
- acute coronary syndrome
- metabolic syndrome